Home
General Info
Venue
Seminars
Instructors/Speakers
Contact Us



 
Registration
Agenda
Venue
Keynote
Plant Tour
Sponsorships
Exhibits
Networking
Media Partners
Invite a Colleague
CONTACT:
Jennifer Delda
Program Manager
deldaj@asme.org





Testimonials:

A truly excellent seminar and a MUST for anyone looking for a detailed overview of industry trends from the technical leaders in the area.

- Ken Carroll, Head of Dept. of Science, Institute of Technology Tallaght - Dublin


An excellent way to acquire a mixture of broad and detailed knowledge about bioprocess equipment design factors.

- Val Peyton, Group Quality Manager, PM Group, Ireland


Bioprocess Equipment Design seminar provides a fast and efficient way of learning a little bit of the whole chain from design to production.

- Josef Alenius, Quality Manager, Texor AB, Sweden


These seminars should be integral to the biotech industry and help harmonise important issues.

- Peter Kierans, Sales Director, Optima Pharma Group, UK


VIEW OTHER TESTIMONIALS






PD315 - Bioreactor Process Technology

Date: October 1-4, 2007 (Monday-Thursday)
CEUs: 3.0


Description

The fundamental principles involved in the engineering of cellular systems for large-scale production of active proteins and stem cells are presented to familiarize engineers and life scientists with factors activating and limiting their bioreactor systems.

Participants will become familiar with the characteristics of proteins, cellular metabolism and physiology as they impact bioreactor development, design and operation. Critical comparisons among mammalian and other culture systems for protein production are made.

The seminar extensively discusses bioreactor development, selection and design, monitoring and control, and large-scale operational issues. Relationship between large scale bioreactor cell culture and other aspects of production, facility and regulatory compliance are discussed.


What You Will Learn

  • Importance of cell culture derived biopharmaceuticals.
  • Role of molecular biology in the production of biopharmaceuticals.
  • Bioreactor design and production of biopharmaceuticals.
  • Bioreactor cell culture as it relates to other aspects of producing a biopharmaceutical; purification, final formulation, facility, clinical development, regulatory compliance


Who Should Attend

Engineers and Scientists who are involved with biopharmaceuticals derived from cell culture and who are part of research, development, production, quality control, quality assurance, regulatory affairs and clinical development will benefit from this course.


Schedule



Sunday, September 30, 2007
3:00 pm - 7:00 pm Registration Open - Avoid the lines on Monday
Monday, October 1, 2007
7:30 am - 8:30 am Registration Desk Open; Continental Breakfast
8:30 am - 9:15 am
The Role of Process Technology
Placement of process technology in the product life cycle.

Frank Abbato
Senior Process Engineer,
DME Alliance

9:15 am - 10:00 am
Expression of Biopharmaceuticals in Mammalian Cells - Vectors and Host Cells, part 1
Review of host cells and expression vector systems for the production of biopharmaceuticals using mammalian cells. General approaches for improving cell line productivity and production economy using the latest molecular biology and cell culture techniques.

Arnold H. Horwitz
Senior Director, Cell Biology
XOMA (US) LLC

10:00 am - 10:30 am
Refreshment Break
10:30 am - 12:00 noon
Expression of Biopharmaceuticals in Mammalian Cells - Vectors and Host Cells, part 2,
Improving Expression of Biopharmaceuticals in Mammalian Cells - Industrial Examples, part 1

Approaches for improving production of biopharmaceuticals using mammalian cells. Specific examples of improving cell line productivity and production economy using the latest molecular biology and cell culture techniques.

Arnold H. Horwitz
Senior Director, Cell Biology
XOMA (US) LLC
12:00 noon - 1:00 pm
Lunch
1:00 pm - 1:45 pm

Improving Expression of Biopharmaceuticals in Mammalian Cells - Industrial Examples, part 2
Approaches for improving production of biopharmaceuticals using mammalian cells. Specific examples of improving cell line productivity and production economy using the latest molecular biology and cell culture techniques.

Arnold H. Horwitz
Senior Director, Cell Biology
XOMA (US) LLC
1:45 pm - 2:30 pm

Media Design for Life Cycle Process Validation
Media Design considerations with case studies for anticipating future process changes and ease of maintaining process validation.

Frank Abbato
Senior Process Engineer,
DME Alliance
2:30 pm - 3:00 pm
Refreshment Break
3:00 pm - 5:00 pm
Expression of Biopharmaceuticals in Microbial Cells
Approaches for improving production of biopharmaceuticals using microbial cells. Specific examples of improving cell line productivity and production economy using the latest molecular biology and microbial techniques.
Arnold H. Horwitz
Senior Director, Cell Biology
XOMA (US) LLC
5:00 pm - 6:00 pm Networking Hour
Tuesday, October 2, 2007
7:30 am - 8:30 am Registration Desk Open; Continental Breakfast
8:30 am - 10:00 am Developing for Scalability
How to adequately explore the process development design space to ensure future scalability. Implementation of new technologies to model and analyze cell culture operations before and during scale-up are also discussed.
Ben Beneski
Senior Manager, Amgen
10:00 am - 11:00 noon Discussion of Feeding Strategies, pH control, and DO control in large scale bioreactors
Leveraging advances in large scale cell culture methodology to maximize process development results.
Scott Richmond
Senior Scientist
Human Genome Sciences
11:00 am - 11:15 am
Refreshment Break
11:15 - 12:00 noon KEYNOTE
12:00 noon - 1:00 pm
Lunch
1:00 pm - 2:30 pm
Mammalian Cell Culture in the Production Scale Bioreactor
Operation of large-scale 20,000 liter mammalian cell bioreactors in an FDA-regulated environment. Extrapolation of pilot scale bioreactor production information to large scale cell culture production and purification in a GMP production environment.
Joseph Kauten
Lonza Biologics
2:30 pm - 3:00 pm
Refreshment Break
3:00 pm - 5:00 pm
Pitfalls in Large Scale Bioreactor Design
Examination of process and equipment problems and solutions encountered in large scale cell culture operations.
Ben Beneski
Senior Manager, Amgen
5:00 pm - 7:00 pm Opening Reception with Exhibitors
Wednesday, October, 3, 2007
7:30 am - 8:30 am Registration Desk Open; Continental Breakfast w/ Exhibitors
8:30 am -10:00 am
Bioreactor Engineering - Mass Transfer, Heat Transfer and Agitation Design
This presentation will explore the principles and practice of stirred-tank bioreactor design and scale-up for fermentation and cell culture.
 
David Marks
President and Founder
DME Alliance Inc.
10:00 am - 10:30 am
Refreshment Break w/ Exhibitors
10:30 am - 12:00 noon
Bioreactor Engineering - Equipment Design
We will survey best practice for bioreactor equipment design, CIP, SIP, and lessons learned from implementations in pilot and production-scale GMP facilities.
David Marks
President and Founder
DME Alliance Inc.
12:00 noon - 1:00 pm
Lunch w/ Exhibitors
1:00 pm - 3:00 pm
Optimizing a Process within Existing Bioreactors
Methods for process optimization when restricted by existing facilities and processes.
Scott Richmond
Senior Scientist
Human Genome Sciences
3:00 pm
Refreshment Break w/ Exhibitors
Thursday, October 4, 2007
7:30 am - 8:30 am Registration Desk Open; Continental Breakfast w/ Exhibitors
8:30 am - 10:00 am
Regulatory Aspects of Biopharmaceutical Product Development
Overview of pragmatic solutions during biopharmaceutical product development. Regulatory aspects of "Generic" Bio-Similar Biopharmaceuticals.
Anthony Moreira
Vice Provost for Academic Affairs UMBC
10:00 am - 10:30 am
Refreshment Break with Exhibitors
10:30 am - 12:00 noon
Applied Agitator Design for Bioreactors
A practical survey of best practice for agitator design within GMP bioreactors and the process impact (mixing, shear, reliability, cleanability, aseptic operation) of agitator design selections.

Paul Kubera
Vice President Engineering
ABEC, Inc.
12:00 noon - 1:00 pm
Lunch w/ Exhibitors
1:00 pm - 2:30 pm Biopharmaceutical Product Development Workshop
Seminar participants will outline the tasks and timelines for the development of an example protein product, taking into consideration future scale-up concerns for the products expected market volume.
Panel Workshop
Moderator: Frank Abbato
All Instructors
2:30 pm - 3:00 pm Refreshment Break
3:00 pm - 5:00 pm Biopharmaceutical Product Development Workshop - cont'd.
Seminar participants will outline the tasks and timelines for the development of an example protein product, taking into consideration future scale-up concerns for the products expected market volume.
Panel Workshop
Moderator: Frank Abbato
All Instructors
5:00 pm - 6:00 pm
Networking Hour
Friday, October 5, 2007
9:00 am - 10:30 am
PLANT TOUR - Genentech Oceanside (Advance Sign-up required)


ASME Travel Policy : ASME is not responsible for the purchase of non-refundable airline tickets or the cancellation/change fees associated with canceling a flight. Please call to confirm that the course is running before purchasing airline tickets. ASME retains the right to cancel a course up until 3 weeks of the scheduled presentation date.




Produced By
Sponsors
ASME
Premier Media Sponsor Supporting Publication Supporting Organization
Supporting ASME Units 
           

Copyright © 1996-2008 ASME. All Rights Reserved. Terms of Use | Privacy Statement
Powered by Conference Toolbox ™ version 4.0. For more information, contact us.